This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Analysts' Actions: TOL PCLN CSCO AFL FRX

NEW YORK (TheStreet) -- CHANGE IN RATINGS

American Electric (AEP) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $46 price target. Estimates also boosted, given the company's new rate plan in Ohio.

Aflac (AFL) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. Company has little margin to take future credit losses.

Cisco Systems (CSCO) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $22 price target. Expect solid near-term results and guidance.

Forest Laboratories (FRX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $37 price target.

Hospira (HSP) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $38 price target.

Int'l Flavors & Fragrances (IFF) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $65 price target.

Interpublic (IPG) upgraded at Nomura from Neutral to Buy, Nomura said. Valuation call, based on a $13 price target.

Allscripts (MDRX) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $15 price target.

NetApp (NTAP) downgraded at Cantor from Buy to Hold, Cantor Fitzgerald said. Company can continue to struggle with enterprise demand. $38 price target.

Priceline.com (PCLN) downgraded at Lazard from Buy to Neutral, Lazard said. Company is facing increased competition and Europe remains slow.

PulteGroup (PHM) upgraded at JP Morgan to Overweight, JP Morgan said. $15 price target. Housing fundamentals should continue to improve over the next 18 months.

PPL Corp (PPL) upgraded at UBS to Buy from Neutral, UBS said. $31 price target. Cost savings initiative.

Select Medical (SEM) downgraded at UBS to Neutral from Buy, UBS said. $14 price target. Reducing rating following strong rally.

Salix Pharmaceuticals (SLXP) upgraded at Cantor to Buy, Cantor Fitzgerald said. $60 price target. Estimates also upped, as the company is cutting costs.

Toll Brothers (TOL) downgraded at JP Morgan to Underweight, JP Morgan said. Valuation call, based on a $30 price target.

Trimble (TRMB) rated new Buy at Lazard. $58 price target.

Stock quotes in this article: EBAY, TOL, PCLN, CSCO, AFL, FRX, HSP, MDRX, NTAP 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs